A brain implant to treat depression gets FDA greenlight to start trials - Popular Science

A new type of brain implant could give scientists a more precise way to study the brain and may eventually contribute to treatments for neurological conditions such as epilepsy. Researchers from DTU, the University of Copenhagen, University College London, and other institutions have developed a long, needle-thin brain electrode equipped with microscopic channels. Known as the microfluidic Axialtrode (mAxialtrode), the device is designed to provide multiple functional points along the length of the implant. This allows researchers to record neural activity and deliver medication to specific locations across different parts of the brain.

The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. The US Food and Drug Administration’s scientific advisory committees that help the agency make decisions around health policy and other topics are convening far less often.

Senior leaders from Novartis, Eli Lilly, Pfizer, Takeda, Menarini, GSK, AstraZeneca, Novo Nordisk and other global pharmaceutical companies, alongside leading academics, investors, regulators and biotechnology innovators Newly announced highlights include a pharma chief executive panel, an FDA and ARPA-H regulatory discussion, the XPRIZE Healthspan finalists, and dedicated forums on AI drug discovery, pet longevity and virtual aging cells